Plasmatech Biopharma, Inc. (PTBI) Starts Presentation at 2015 Marcum MicroCap Conference

PlasmaTech Biopharmaceuticals is a biopharmaceutical company in the business of developing protein biologic therapies and oncology supportive care products. The company’s products are MuGard for the management of oral mucositis and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region. It also develops CobaCyte, a mediated targeted delivery technology that has application in in tumor targeting. For more information, visit the company website at www.plasmatechbio.com